"Even with careful monitoring by dialysis professionals, needles do become dislodged, and significant blood loss can occur before dislodgement is detected." Patrik Byhmer, CEO of Redsense Medical, explains. "Other monitoring systems rely on blood pressure or moisture detectors and the reliability of those techniques is uncertain at best. The Redsense blood loss detection device has been clinically tested and is proven to be reliable. Patients can change position or rest without risking an undetected dislodgement. For care providers, this device offers unprecedented peace of mind and the freedom to move freely around the unit."
Redsense consists of two parts: a sensor patch and an alarm unit. An infrared signal is transmitted from the alarm unit to the sensor patch using fiber optic cable. In the event of bleeding, inner layers of the patch smear blood over the optical sensor, which triggers the alarm. Redsense doesn't react to perspiration or water, so moisture alone will not cause an alarm. And because the signal to the sensor is continuous, the alarm reacts instantly to the first milliliter of blood. Nurses and doctors are free to focus on the tangible problems of hemodialysis. And the patient can benefit from the care of professionals who feel in control of their situation.
About Redsense Medical
After a number of incidents with venous needle dislodgement during
hemodialysis at a dialysis clinic in Sweden, the clinic's technicians
contacted a company specializing in medical technology. This cooperation
between medical staff and engineers resulted in the startup of Redsense
Medical in 2006. Redsense Medical has offices in Sweden and in the U.S.
(Seattle, WA). For more information, contact Redsense Medical Ltd., 1750,
112th AVE NE #E170, Bellevue, WA, 98004; Phone: (425) 503 8188; Fax: (425)
688 0813; Email:
'/>"/>
| SOURCE Redsense Medical Copyright©2007 PR Newswire. All rights reserved |